Regenerative Therapies 2008: 1st International Clinical Development Congress in Cell Therapies and T

Venue: London

Location: London, United Kingdom

Event Date/Time: Oct 23, 2008 End Date/Time: Oct 24, 2008
Report as Spam


Advancements in stem cell research and tissue engineering hold the promise of introducing a new trove of regenerative therapies to treat diseases and conditions by restoring or repairing genetic and cellular defects. Over the past decade alone billions of dollars of investment have poured into the sector, and with over 550 global companies developing or collaborating on regenerative products, the clinical development stakes are high. Understanding the current challenges and the technological advances is critical for successful transition from bench to clinic.

Arrowhead-Spectra’s 1st International Clinical Development Congress in Cell Therapies and Tissue Engineering is the forum to decipher the progress of clinical-phase candidates and technologies that have the potential to succeed in the highly competitive global marketplace. Based on presentations of case studies, trials, and proprietary data, the conference will be an unmissable event that focuses pioneering clinical development work.

We invite both companies and academia to send us abstracts for product- or market-related presentations that we will considered for the event. If you would like to discuss any proposals further or would like to sponsor this international conference, please contact us at

Why Attend

* Determine the progress of current clinical-phase products in cell therapies and tissue engineering;
* Better understand the challenges and opportunities in stem cells and bioengineering;
* Learn from pioneering companies on progress of lead products and technologies;
* Determine the efficacy of clinical stage regenerative products;
* Establish the market leaders in cell therapy and tissue engineering areas;
* Network with leaders from bioengineering, pharma-biotechnology and healthcare industries.

Who Should Attend

Individuals from regenerative, biotechnology, pharmaceutical, capital investment companies will greatly benefit from attending. Executive and professional job types may include:

* Senior executive management: CEO, VP, CSO
* Research and development executives
* Academic research scientists
* Medical scientists
* Healthcare media organizations
* Medical and healthcare journalists
* Venture capitalists